300
Participants
Start Date
February 28, 2025
Primary Completion Date
November 15, 2028
Study Completion Date
December 15, 2028
ECHOCARDIOGRAPHY
A complete echocardiographic exam will be performed during each cardio-oncologic evaluation.
ELECTROCARDIOGRAPHY (ECG)
An ECG tracing will be obtained during each cardio-oncologic evaluation.
LABORATORY TESTS
The cardiac biomarkers high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP) will be dosed according to the current recommendations of Cardio-Oncology Guidelines.
RECRUITING
Fondazione Policlinico Universitario A. Gemelli IRCCS;UOSD diagnostica cardiologica non invasiva, Rome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER